Trials / Completed
CompletedNCT05200000
Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis
Evaluation of Wharton's Jelly Extract Eye Drops, Treated by the AMTRIX Process, in the Treatment of Chronic Keratitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- TBF Genie Tissulaire · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this open, non-comparative, multicenter trial is to assess the impact of eye drops made of Wharton's jelly extract in the treatment of chronic keratitis that failed available therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SygeLIX-Coll-T | Reconstituted suspension made of Trehalose and chemically treated, grinded, freeze-dried and sterilized Wharton's Jelly used by the patient as eye drops. |
Timeline
- Start date
- 2020-01-08
- Primary completion
- 2023-06-20
- Completion
- 2023-06-20
- First posted
- 2022-01-20
- Last updated
- 2024-02-20
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05200000. Inclusion in this directory is not an endorsement.